Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ device, dubbed Sapien M3, is the first ...

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

(RTTNews) - Roche (RHHBY) announced that it received CE Mark for its Chest Pain Triage ... reasons for Emergency Department visit. This new algorithm was developed in collaboration with ...

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

“Optune Lua is an innovative and urgently needed new approach for treating metastatic ... resulting in cell death. “The CE Mark approval for Optune Lua for metastatic non-small cell lung ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

What’s new in AI healthcare? DeepTek’s Chest X-ray AI now identifies 20+ lung conditions with EU MDR certification!

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt PFA SystemThe 12-month results of the ...

Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure. Vivasure’s device is designed ...